These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 7789083)

  • 21. Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases.
    Clissold SP; Lynch S; Sorkin EM
    Drugs; 1987 May; 33(5):430-60. PubMed ID: 3297620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [is there a treatment for peripheral arterial insufficiency?].
    Zicot M
    Rev Med Liege; 1979 Jan; 34(2):48-51. PubMed ID: 368938
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevention studies with pentoxifylline: new clinical projects.
    Eugène-Jolchine I; Milpied N
    J Cardiovasc Pharmacol; 1995; 25 Suppl 2():S143-6. PubMed ID: 8699855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drugs in cerebral and peripheral arterial disease.
    Lowe GD
    BMJ; 1990 Feb; 300(6723):524-8. PubMed ID: 2107935
    [No Abstract]   [Full Text] [Related]  

  • 25. [Medical treatment of peripheral occlusive arteriopathies. Possibilities, principles and basis].
    Heidrich H
    Minerva Med; 1979 Oct; 70(47):3255-63. PubMed ID: 390422
    [No Abstract]   [Full Text] [Related]  

  • 26. An experimental overview of a new vasoactive drug: buflomedil HCl.
    Dubourg A; Scamuffa RF
    Angiology; 1981 Oct; 32(10):663-75. PubMed ID: 7034590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antioxidant and metabolic therapy of lower limb chronic obliterative arterial disease].
    Koshkin VM; Murav'ev SV; Dadova LV; Kalashov PB
    Angiol Sosud Khir; 2006; 12(3):29-32. PubMed ID: 17641611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The clinico-pharmacological activity of Agapurin].
    Chekman IS; Svintsyts'kyĭ AS; Bondur VV; Zahorodnnyĭ MI
    Lik Sprava; 1999 Sep; (6):6-12. PubMed ID: 10626429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of chronic obliterative arteriopathy of the legs in the second Fontaine's stage. Personal experience with a buflomedil-pentoxifylline-defibrotide combination].
    Marci M; Albiani B; Ricci M; Russo F
    Clin Ter; 1995 Mar; 146(3):211-4. PubMed ID: 7789083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Walk training and drug treatment in patients with peripheral arterial occlusive disease stage II. A review.
    Spitzer S; Bach R; Schieffer H
    Int Angiol; 1992; 11(3):204-10. PubMed ID: 1460355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    J Med; 1988; 19(2):89-107. PubMed ID: 3049876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral arterial disease: drug therapy.
    Schwartz JB
    J Gend Specif Med; 2002; 5(4):16-20. PubMed ID: 12192882
    [No Abstract]   [Full Text] [Related]  

  • 33. [The use of pentoxyphylline in the treatment of patients with chronic obliterative diseases of lower limb arteries].
    Koshkin VM
    Angiol Sosud Khir; 2005; 11(4):141-7. PubMed ID: 16474301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.